IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
SAINT-LAURENT, Quebec, Dec. 08, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces...
News
Way2Grow (W2G) Biopharma Company Receives Health Canada Standard Cultivation License, Processing License and Medical Sales License
OSOYOOS, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately owned...
Altimmune Commences Dosing in Phase 1 Clinical Trial of ALT-801, a Long-Acting GLP-1/Glucagon Receptor Dual Agonist for the Treatment of NASH
Preclinical data suggest potential for ALT-801 to address a significant unmet medical need; Phase 1 data readout anticipated in Q2...
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development Programs
HPN424 has shown confirmed partial response in treatment of metastatic castration-resistant prostate cancer in highest fixed dose cohort (160 ng/kg)...
Capital Senior Living Commences Planned Community Transitions, Reducing Long-Term Liabilities and Improving Net Operating Income
DALLAS, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU) announced it has completed the...
Chinook Therapeutics Announces License Agreement with Morehouse School of Medicine for Development of Therapies in Kidney Diseases Disproportionately Affecting African Americans and Underserved Communities
VANCOUVER, British Columbia and SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biopharmaceutical company...
Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer
· Phase 1b Data Expected 1H 2021 MINNEAPOLIS, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a...
Aditxt to Present at the 13th Annual LD Micro Main Event Conference
Presentation on Tuesday December 15th at 11:00am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --...
electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study
BASKING RIDGE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today top-line...
Kronos Bio Appoints Pasit Phiasivongsa, Ph.D., as Senior Vice President, Pharmaceutical Development
SAN MATEO, Calif. and CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated...
BBS-Bioactive Bone Substitutes Plc: The information published in the Company Announcement by BBS-Bioactive Bone Substitutes Plc. on 9 November 2020 at 8:45 has proved to be incorrect
On 9 November 2020 at 8:45 am BBS-Bioactive Bone Substitutes Plc (”BBS”, ”the Company”) published an announcement concerning the acceptance...
Neumentum to Present New Data for Drug Candidate NTM-001 at the 2020 ASHP Midyear Clinical Meeting and Exhibition
Results from evaluation of novel non-opioid analgesic NTM-001, under development for post-surgical pain, support pathway to potential Phase 3 pivotal...
Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement
Centers for Medicare & Medicaid Services sets a 66% increase in reimbursement for Radiation Treatment Delivery code 77401, and increases...
Amolyt Pharma Announces Research Collaboration with PeptiDream
Amolyt and PeptiDream will collaborate to optimize and evaluate growth hormone receptor antagonists to select a candidate for clinical development...
Mydecine Innovations Group to Make First Commercial Export of Legal Psilocybin Mushrooms
Mydecine completes harvest and is preparing to export 20 kilograms of psilocybin mushrooms from Jamaica to Canada for increased global...
Progenity Announces Closing of the Convertible Senior Notes Offering and Partial Exercise of the Initial Purchaser’s Option to Purchase Additional Notes
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record...
Jushi Holdings Inc.’s Retail Brand, BEYOND / HELLO, and Holistic Industries Collaborate to Bring “Garcia Hand Picked” to Santa Barbara Cannabis Consumers
New Strains of Garcia Hand Picked, Merchandise and Accessories Now Available for Purchase at BEYOND / HELLO™ Santa Barbara Jushi...
Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer’s Disease
SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Progenity Announces Closing of Public Offering of Common Stock
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (NASDAQ: PROG), a biotechnology company with an established track record...
Cerevel Therapeutics Announces the Appointment of Dr. Ruth McKernan to its Board of Directors
CAMBRIDGE, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...